An in vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.
Features and Benefits
Technical Specifications
Features and Benefits
- Includes positive and negative control swabs
- Innovative flip design with onboard sample extraction
- Pre-measured developer solution capsule for increased accuracy and ease of use
- Available results in 10 minutes .
- Flocked nasal swab for improved patient comfort and superior specimen collection
- CLIA waived for nasal swab and nasopharyngeal swab samples
Technical Specifications
- Influenza A:
- Positive % Agreement: 89.2%
- Negative % Agreement: 99.4%
- Influenza B:
- Positive % Agreement: 86.4%
- Negative % Agreement: 99.0%
- CPT Code 87084QW: Influenza A; National Average - $15.39
- CPT Code 87084QW-59: Influenza B; National Average - $15.39
RETURNS :
For complete details of our return policy and process, please refer to our general return policy page. We take the responsibility to make sure your product
arrives in brand new working condition. Should your item arrive damaged, we will replace the product at no cost to you.
CANCELLATIONS: Please note that any specially ordered or custom-made products are non-cancellable once production has begun. Unfortunately, we are unable to
accept returns on such items.
AVAILABILITY NOTE: Availability of products may vary based on the manufacturer’s current stock levels.
